Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability
Table 6
Comparison of lipid pattern in osteosarcoma patients before and after therapy.
TG (mmol/L)
TC (mmol/L)
HDL-C (mmol/L)
LDL-C (mmol/L)
MDA (mmol/L)
Before
NG
2.8 ± 1.2
5.7 ± 1.2
1.3 ± 0.3
3.8 ± 1.0
1.7 ± 0.3
CG
2.7 ± 1.1
5.6 ± 1.2
1.2 ± 0.2
4.0 ± 1.1
1.6 ± 0.2
P value
0.73
0.86
0.64
0.76
0.89
8-month
NG
2.6 ± 1.3
5.5 ± 1.1
1.4 ± 0.2
3.5 ± 1.1
1.5 ± 0.2
CG
2.7 ± 1.3
5.7 ± 1.1
1.3 ± 0.2
3.9 ± 1.1
1.7 ± 0.3
P value
0.34
0.22
0.18
0.26
0.27
16-month
NG
2.2 ± 1.3
5.1 ± 1.1
1.6 ± 0.2
3.2 ± 1.1
1.3 ± 0.2
CG
2.8 ± 1.3
5.8 ± 1.1
1.3 ± 0.2
4.0 ± 1.2
1.8 ± 0.3
P value
0.02
0.04
0.04
0.03
0.02
24-month
NG
1.8 ± 1.1
4.6 ± 1.4
1.6 ± 0.3
3.0 ± 1.1
0.9 ± 0.1
CG
2.6 ± 1.3
5.5 ± 1.1
1.2 ± 0.2
3.9 ± 1.2
1.6 ± 0.3
P value
0.01
0.02
0.01
0.01
0.01
Note: t-test calculator for two independent means. via CG.
